Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.54 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.54 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.54 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.54 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20152539 | 0.90 | CRBN (0.53) | MAPK1HTTCRBNPIK3CDPIK3CA | |
| SCHEMBL22507273 | 0.88 | CRBN (0.54) | MAPK1HTTCRBNPIK3CDPIK3CA | |
| SCHEMBL6461042 | 0.87 | ESR2 (0.57) | MAPK1HTTCRBNPIK3CDPIK3CA | |
| SCHEMBL14499601 | 0.87 | CRBN (0.53) | MAPK1HTTCRBNPIK3CDPIK3CA | |
| SCHEMBL11901863 | 0.86 | MAPK1 (0.57) | MAPK1HTTCRBNCYP1A2PDE10A | |
| SCHEMBL11901164 | 0.86 | MAPK1 (0.57) | MAPK1HTTCRBNCYP1A2PDE10A | |
| SCHEMBL10897042 | 0.86 | MAPK1 (0.57) | MAPK1HTTCRBNCYP1A2PDE10A | |
| SCHEMBL11901680 | 0.86 | MAPK1 (0.57) | MAPK1HTTCRBNCYP1A2PDE10A | |
| SCHEMBL22507450 | 0.84 | GSR (0.52) | MAPK1HTTCRBNPIK3CDPIK3CA | |
| SCHEMBL22507268 | 0.84 | CRBN (0.51) | MAPK1HTTCRBNPIK3CDPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11618757-B2 | Polycyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2023-04-04 | — | — | US | disclosed |
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | CHANGCHUN HYPERIONS TECH CO LTD (CN) | 2023-01-26 | — | — | US | disclosed |
| EP-4101841-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-12-14 | — | — | EP | disclosed |
| US-20210351364-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | SK MATERIALS JNC CO., LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
| US-11001752-B2 | Double spiro organic compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2021-05-11 | — | — | US | disclosed |
| US-20210135119-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2021-05-06 | — | — | US | disclosed |
| US-20210119139-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-04-22 | — | — | US | disclosed |
| US-10968230-B2 | Spiro-structured compound and organic electronic device comprising same | LG CHEM, LTD. | 2021-04-06 | — | — | US | disclosed |
| US-20210020852-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-21 | — | — | US | disclosed |
| US-10892419-B2 | Space-through charge transfer compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2021-01-12 | — | — | US | disclosed |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-09-17 | — | — | US | disclosed |
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-08-13 | — | — | US | disclosed |
| US-20090153039-A1 | Green electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| EP-2067766-A1 | Green electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-06-10 | — | — | EP | disclosed |
| EP-2067767-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-06-10 | — | — | EP | disclosed |
| US-20070142369-A1 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | SCHERING CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-20070142369-A1 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | SCHERING CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-20070107835-A1 | ETHYNYL CONTAINING ELECTRON TRANSPORT DYES AND COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY | 2007-05-17 | — | — | US | disclosed |
| US-7192657-B2 | Ethynyl containing electron transport dyes and compositions | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10892419-B2 | Space-through charge transfer compound, and organic light emitting diode and display device using the same | NLRP1, NLRP3, CYBA | MAPK1 2890/4885HTT 2976/4885CRBN 895/4885 |
| US-20070142369-A1 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | CNR2, GPR119, GLP1R | MAPK1 3216/4885HTT 267/4885CRBN 3662/4885 |
| US-20210119139-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | C1S, CRY1, SOS1 | MAPK1 1127/4885HTT 1613/4885CRBN 493/4885 |
| US-20090230852-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OXER1, L1CAM, RPL41 | MAPK1 640/4885HTT 2108/4885CRBN 1419/4885 |
| US-20210135119-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | MAPK1 4873/4885HTT 815/4885CRBN 2694/4885 |
| US-10968230-B2 | Spiro-structured compound and organic electronic device comprising same | ESR1, OR10J3, ERG | MAPK1 3296/4885HTT 2875/4885CRBN 2960/4885 |
| US-20090200926-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | NQO1, NDUFS2, NDUFS5 | MAPK1 1347/4885HTT 1693/4885CRBN 2909/4885 |
| US-11618757-B2 | Polycyclic compound and organic light emitting element comprising same | CRY1, CRY2, PER2 | MAPK1 1964/4885HTT 3623/4885CRBN 1307/4885 |
| US-20230025656-A1 | TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | TRDMT1, TCF4, TRMT1 | MAPK1 4053/4885HTT 114/4885CRBN 4668/4885 |
| US-20090153039-A1 | Green electroluminescent compounds and organic electroluminescent device using the same | C1S, ACSL3, CCNL2 | MAPK1 1635/4885HTT 1153/4885CRBN 3921/4885 |
| US-11001752-B2 | Double spiro organic compound and organic electronic element comprising same | DCX, TERT, TELO2 | MAPK1 2136/4885HTT 830/4885CRBN 1640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.